Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt

Standard

Use of antimicrobial growth promoters in food animals : The risks outweigh the benefits. / Wegener, H. C.

Antimicrobial Growth Promoters: Where do we go from here?. Wageningen Academic Publishers, 2006. s. 53-58.

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt

Harvard

Wegener, HC 2006, Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits. i Antimicrobial Growth Promoters: Where do we go from here?. Wageningen Academic Publishers, s. 53-58. https://doi.org/10.3920/978-90-8686-570-3

APA

Wegener, H. C. (2006). Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits. I Antimicrobial Growth Promoters: Where do we go from here? (s. 53-58). Wageningen Academic Publishers. https://doi.org/10.3920/978-90-8686-570-3

Vancouver

Wegener HC. Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits. I Antimicrobial Growth Promoters: Where do we go from here?. Wageningen Academic Publishers. 2006. s. 53-58 https://doi.org/10.3920/978-90-8686-570-3

Author

Wegener, H. C. / Use of antimicrobial growth promoters in food animals : The risks outweigh the benefits. Antimicrobial Growth Promoters: Where do we go from here?. Wageningen Academic Publishers, 2006. s. 53-58

Bibtex

@inbook{eab206df14214be0a4b6969e70dbb1e5,
title = "Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits",
abstract = "Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.",
keywords = "Antimicrobial growth promoters, Antimicrobial resistance, Benefits, Risks",
author = "Wegener, {H. C.}",
year = "2006",
month = dec,
day = "1",
doi = "10.3920/978-90-8686-570-3",
language = "English",
isbn = "9789076998879",
pages = "53--58",
booktitle = "Antimicrobial Growth Promoters",
publisher = "Wageningen Academic Publishers",
address = "Netherlands",

}

RIS

TY - CHAP

T1 - Use of antimicrobial growth promoters in food animals

T2 - The risks outweigh the benefits

AU - Wegener, H. C.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.

AB - Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.

KW - Antimicrobial growth promoters

KW - Antimicrobial resistance

KW - Benefits

KW - Risks

UR - http://www.scopus.com/inward/record.url?scp=70349844873&partnerID=8YFLogxK

U2 - 10.3920/978-90-8686-570-3

DO - 10.3920/978-90-8686-570-3

M3 - Book chapter

AN - SCOPUS:70349844873

SN - 9789076998879

SP - 53

EP - 58

BT - Antimicrobial Growth Promoters

PB - Wageningen Academic Publishers

ER -

ID: 228689722